1. Шамхалова М.Ш., Зайцева Н.В., Шестаков М.В. Контрастиндуцированная нефропатия у больных сахарным диабетом. Трудный пациент. 2007; 4.
2. Morcos S, Thomsen HS, Webb JAW and Members of the Contrast Media Safety Commit-Tee of the European Society of Urogenital Radiology (Esur): Contrast Media Induced Nephrotoxic-Ity: a Consensus Report. Eur Radiol 1999; 9: 1602–13.
3. Thomsen H, Morcos S. Contrast Media and the Kidney: European Society of Urogenital Radiology (Esur) Guide-Lines. Br J Radiol 2003; 76: 513–8.
4. Thomsen H. Guidelines for Contrast Media from the European Society of Urogenital Radiology. Ajr 2003; 81: 1463–71.
5. Mccullough P, Sandberg KA. Epidemiology of Contrast-Induced Nephropathy. Rev Cardiovasc Med 2003; 4 (Suppl. 5): S3–S9.
6. Mccullough P, Wolyn R, Rocher LL et al. Acute Renal Failure after Coronary Intervention: Incidence, Risk Factors, and Relationship to Mortality. Am J Med 1997; 103: 368–75.
7. Rihal C, Textor SC, Grill DE et al. Incidence and Prognostic Importance of Acute Renal Failure after Percutane-Ous Coronary Intervention. Circulation 2002; 105: 2259–64.
8. Murphy S, Barrett BJ, Parfrey PS. Contrast Nephropathy. J Am Soc Nephrol 2000; 11: 117–82.
9. Gutierrez N, Diaz A, Timmis GC. Determinants of Serum Creatinine Trajectory in Acute Contrast Nephropathy. J Interv Cardiol 2002; 15: 349–54.
10. Levy E, Viscoli CM, Horwitz RI. The Effect of Acute Renal Failure on Mortality. A Cohort Analysis. Jama 1996; 275: 1489–94.
11. Gruberg L, Mintz, GS, Mehran R et al. The Prognostic Implications of Further Renal Function Deterioration within 48 h of Interventional Coronary Procedures in Patients with Pre-Existent Chronic Renal Insufficiency. J Am Coll Cardiol 2000; 36: 1542–8.
12. Best P, Lennon R, Ting HH et al. The Impact of Renal Insufficiency on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Interventions. J Am Coll Cardiol 2002; 39: 1113–9.
13. Rudnick M, Goldfarb S, Wexler L et al. Nephropathy of Ionic and Nonionic Contrast Media in 1196 Patients: a Randomized Trial. Kidney Int 1995; 47: 254–61.
14. Taliercio C, Vlietstra RE, Ilstrup DM et al. a Randomized Comparison of Nephrotoxicity of Iopamidol and Diatrizoate in High Risk Patients Undergoing Cardiac Angiography. J Am Coll Cardiol 1991; 17: 384–90.
15. Barrett B, Carlisle EJ. Metaanalysis of the Relative Nephrotoxicity of High- and Low-Osmolality Iodinated Con-Trast Media. Radiology 1993; 188: 171–8.
16. Aspelin P, Aubry P, Fransson S et al. Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. N Engl J Med 2003; 348: 491–9.
17. Solomon RJ. The Role of Osmolality in Incidence of Contrast-Induced Nephropathy: a Systematic Review of Angiographic Contrast Media in High Risk Patients. Kidney Int 2005; 68: 2256–63.
18. Solomon RJ, Doucet S, Sltarma SK, Cardiac Angiography in Renally Impaired Patients (Care) Study: a Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease. Circulation 2007; 115: 3189–96.
19. Кармазановский Г.Г., Поляев Ю.Д., Юдин А.Л., Шимановский Н.Л. Современные РКС и нефропатия: как снизить риск развития почечной недостаточности? Медицинская визуализация. 2007; 1.
20. Kushner FG, Hand M, Smith SC et al. ACC/AHA Guidelines for the Management of Patients with St-Elevation Myocardial Infarction. Circulation 2009; 120: 2271–306; originally published online 2009.
Авторы
Д.Н.Филатов
Институт клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ